Three-Dimensional Transthoracic Echocardiography as a Tool for Patient Selection for Percutaneous Atrial Septal Defect Closure

• by Talya Finke, Uriel Katz, Tal Grupel, Yarden Sarouf Gat, Gur Mainzer, Sharon Borik Chiger

• September 12, 2026

Ventricular Strain and Correlation with Cardiovascular Symptoms and Pulmonary Function Testing in Pediatric Patients with a History of COVID-19: Results from the Pediatric SARS-CoV-2 Long Term Outcomes Study

• by Michael He, Thomas R. Burklow, Craig A. Sable, Stephanie R. Lacey, James E. Bost, Andrew J. Lipton, Anastassios C. Koumbourlis, Maggie E.S. Curry, Farokh Choodar, Malgorzata Lasota, Suhyoun Park, Mistir Dubale, Michael DiMaggio, Kevin B. Rubenstein, Karyl Barron, Gina A. Montealegre Sanchez, Roberta L. DeBiasi, Ashraf S. Harahsheh

• July 2, 2026

Risk stratification and real-world management of pediatric AAORCA: discordance between anatomical features and clinical symptoms

• by Jinjin Yu, Shushui Wang, Qinchang Chen, Ping Zhu, Wei Pan

• July 15, 2026

FDA Approves Low-Dose Macrocyclic Contrast Agent for MRI

The macrocyclic gadolinium-based contrast agent has a recommended dose of 0.01 mmol/kg actual body weight.

• by Kathryn Wighton

• June 15, 2026

• 3 min